Stephen Doster

  • Vanderbilt University

    Borden Lacy named director of Vanderbilt’s Center for Structural Biology

    by Marissa Shapiro Jan. 11, 2021, 9:00 AM Borden Lacy (Vanderbilt University) Borden Lacy, Edward and Nancy Fody Chair in Pathology and professor of biochemistry and pathology, microbiology and immunology, has been named director of the Vanderbilt Center for Structural Biology.  She… Read More

    Jan. 11, 2021

  • Vanderbilt University

    Siciliano named to 2021 ‘Forbes’ 30 under 30

    by Marissa Shapiro Jan. 8, 2021, 9:06 AM Vanderbilt alumnus Graham Gaylor and Assistant Professor of Pharmacology Cody Siciliano have been selected for the 2021 Forbes “30 Under 30.” The 10th annual list recognizes 600 entrepreneurs, scientists, activists and entertainers changing the world. Graham… Read More

    Jan. 8, 2021

  • Vanderbilt University

    Genome editing technique “rescues” mice from accelerated aging disorder: study

    Jan. 6, 2021, 10:31 AM by Bill Snyder Researchers from the Broad Institute of Harvard and MIT, the National Institutes of Health (NIH) and Vanderbilt University Medical Center for the first time have used a novel genome-editing technique to “rescue” mice from progeria, a rare genetic disease that causes accelerated… Read More

    Jan. 7, 2021

  • Vanderbilt University

    Vanderbilt researchers take leadership role in COVID-19 vaccine development

    by Marissa Shapiro Dec. 18, 2020, 11:55 AM Work on COVID-19 theraputics at Vanderbilt University Medical Center (VUMC) As the United States and the rest of the world witness the rollout of new vaccines targeting COVID-19—as well as better treatment options to fight the… Read More

    Dec. 18, 2020

  • Vanderbilt University

    Study reveals new strategy for reducing tumor growth, metastasis

    Dec. 17, 2020, 10:05 AM Ann Richmond, MD, Chi Yan, PhD, Jinming Yang, PhD, and colleagues are studying ways to boost antitumor immunity and reduce tumor growth in breast cancer and melanoma. (photo by Donn Jones) by Leigh MacMillan A team of Vanderbilt investigators has discovered that blocking a certain… Read More

    Dec. 17, 2020

  • ANCORA INNOVATIONS – Vanderbilt University | Deerfield

    ANCORA INNOVATIONS – Vanderbilt University | Deerfield

    REQUEST FOR APPLICATIONS Rare Genetic Diseases Opening January 2021 Rolling Submission-Review Ancora Innovations is a collaboration between Vanderbilt University and Deerfield Management, focused on the union of Vanderbilt’s innovative life science discovery efforts and Deerfield’s commitment to accelerating state-of-the-art drug development. Deerfield will fund Ancora Innovation with up to $65… Read More

    Dec. 17, 2020

  • Medium spiny neurons and “sticking” to bad habits

    Medium spiny neurons and “sticking” to bad habits

    By Alexandra Fuller By the time March rolls around, New Year’s resolutions to ditch the expensive lattes and spend less time (and money) shopping online are often far behind us. Activity within the nucleus accumbens, a region of the brain implicated in motivation and addiction, may be at play. Read More

    Dec. 15, 2020

  • Vanderbilt University

    Exploiting viral vulnerabilities

    Dec. 10, 2020, 10:15 AM by Bill Snyder While COVID-19 grabs the headlines, researchers are steadily making progress in the fight against other dangerous viruses. Among them: Eastern Equine Encephalitis Virus (EEEV), one of the most virulent viruses in North America, and the Hendra and Nipah viruses, which are endemic… Read More

    Dec. 10, 2020

  • Vanderbilt University

    Study details early events of inflammatory response

    by Leigh MacMillan Vanderbilt University Medical Center investigators have identified a key molecular player in the early events of the inflammatory response to infection. The findings suggest new therapeutic possibilities for enhancing the inflammatory response to protect against pathogens and for blocking inflammation gone awry in diseases like arthritis and… Read More

    Dec. 10, 2020

  • Vanderbilt University

    Cortez named interim chair in the Department of Biochemistry; York named Impossible Foods chief science officer

    by Marissa Shapiro Dec. 8, 2020, 9:00 AM David Cortez, Richard N. Armstrong Chair for Innovation in Biochemistry and professor of biochemistry, has been named interim chair in the Department of Biochemistry beginning Jan. 1.   John York (Vanderbilt University) David Cortez (Vanderbilt University) This follows the departure of John York, who was recently named chief science… Read More

    Dec. 9, 2020